The Hidden Power of Every Patient Story
FL Voices, is the Follicular Lymphoma Foundation’s flexible patient involvement network. Share your experiences, shape research, and make a difference.
The FLF Super Supporters: Six Years of Impact and Community
People living with follicular lymphoma (FL) have always played a vital role in shaping our work; bringing lived experience to shape research, education and patient support.
Could some people with Follicular Lymphoma Be Cured? New evidence sparks careful optimism
New long-term research is raising one of the most important, and sensitive, questions in follicular lymphoma: could a subset of patients already be cured?
Busting the myth – “trials are for when nothing else works”
Our third myth busting article of the series, where we breakdown the common myths around clinical trials. This article looks at how clinical trials happen at every stage of FL.
Busting the myth: you’ll be a Guinea Pig trying something untested
Our final myth busting article of the series, where we breakdown the common myths around clinical trials with this article focusing on safety at each trial phase.
Myth: “You might Only Get a Sugar Pill?” The truth about placebos and follicular lymphoma trials
Our second myth busting article of the series, where we breakdown the common myths around clinical trials and placebo’s and share about clinical trial work supported the FLF.
Busting the myth: clinical trials are not just about treatment
Our first myth busting article of the series, where we breakdown the common myths around clinical trials and treatment and share about clinical trial work supported the FLF.
Science Simplified: Biomarkers in Follicular Lymphoma – can we better predict outcomes?
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.
Science Simplified: What’s new in treating relapse in FL? Part 2: Targeted Treatment
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.
Science Simplified: What’s new in treating relapse in FL? Part 1: T-cell engaging immunotherapy
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.